J Korean Med Sci.  2025 Apr;40(15):e46. 10.3346/jkms.2025.40.e46.

Quality of Life in Women With Gestational Diabetes Mellitus and Treatment Satisfaction Upon Intermittently Scanned Continuous Glucose Monitoring

• Won S
• Kim HJ
• Park JY
• Oh KJ
• Choi SH
• Jang HC
• Moon JH

• KMID: 2567198
• DOI: http://doi.org/10.3346/jkms.2025.40.e46

Abstract

Background
To assess the quality of life (QoL) and treatment satisfaction with intermittently-scanned continuous glucose monitoring (isCGM) in women with gestational diabetes mellitus (GDM).
Methods
This prospective observational study included 189 women with GDM who completed the Korean version of the Audit of Diabetes-Dependent Quality of Life Questionnaire (K-ADDQoL). Among them, 25 women who utilized isCGM between gestational weeks 30 and 34 completed the Korean version of the Diabetes Treatment Satisfaction Questionnaire change version (K-DTSQc) to evaluate their satisfaction with isCGM during pregnancy.
Results
GDM had a negative impact on the perceived QoL in 89.4% of the women. All 19 domains of the K-ADDQoL were adversely influenced by GDM, with the most significant impact on the freedom to eat (weighted impact score, −6.98 ± 2.49, P < 0.001) and the least impact on the sex life (−0.25 ± 0.80, P = 0.008). Younger women and those treated with insulin perceived themselves as being more affected in their QoL due to GDM. Women perceived to have less effect on their QoL attributed to GDM exhibited higher ΔHbA1c one year after delivery (ΔHbA1c, 0.3 ± 0.4% vs. 0.0 ± 0.4% in less affected vs. more affected women). The utilization of isCGM improved treatment satisfaction (overall satisfaction score, 10.36 ± 9.21, P < 0.001), independent of glycemic control during pregnancy.
Conclusion
Although GDM negatively affects the perceived QoL during pregnancy, attentiveness to GDM management may have a positive impact on long-term glycemic control. Moreover, employing isCGM can enhance treatment satisfaction in women with GDM.

Keyword

Diabetes, Gestational; Quality of life; Satisfaction; Continuous Glucose Monitoring

Figure

• 

  Fig. 1 Results of the ADDQoL: General quality of life during pregnancy and GDM–dependent quality of life (A) and 19 domain–specific items (B). (A) The general quality of life during pregnancy was assessed using the question “In general, my present quality of life is:”, and GDM–dependent quality of life was evaluated by “If I did not have diabetes, my QoL would be:”. (B) Weighted impact score is calculated by multiplying the impact score and the importance score, ranging from –9 to +3. A lower score indicates a worse quality of life. The range for the impact score is from –3 (maximum negative impact) to +1 (positive impact). The range for the importance score is from +3 (very important) to 0 (not at all important).QoL = quality of life, ADDQoL = Audit of Diabetes-Dependent Quality of Life Questionnaire, SD = standard deviation, GDM = gestational diabetes mellitus.

Reference

1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024; 47(Suppl 1):S20–S42. PMID: 38078589.

2. Moon JH, Jang HC. Gestational diabetes mellitus: diagnostic approaches and maternal-offspring complications. Diabetes Metab J. 2022; 46(1):3–14. PMID: 35135076.

3. Kim HY, Ahn KH, Cho GJ, Hong SC, Oh MJ, Kim HJ. Prepregnancy glucose levels within normal range and its impact on obstetric complications in subsequent pregnancy: a population cohort study. J Korean Med Sci. 2023; 38(35):e286. PMID: 37667584.

4. Moon JH, Kim H, Kim H, Park J, Choi W, Choi W, et al. Lactation improves pancreatic β cell mass and function through serotonin production. Sci Transl Med. 2020; 12(541):eaay0455. PMID: 32350130.

5. Sun S, Pellowski J, Pisani C, Pandey D, Go M, Chu M, et al. Experiences of stigma, psychological distress, and facilitative coping among pregnant people with gestational diabetes mellitus. BMC Pregnancy Childbirth. 2023; 23(1):643. PMID: 37679726.

6. Benton M, Silverio SA, Ismail K. “It feels like medically promoted disordered eating”: The psychosocial impact of gestational diabetes mellitus in the perinatal period. PLoS One. 2023; 18(7):e0288395. PMID: 37478148.

7. OuYang H, Chen B, Abdulrahman AM, Li L, Wu N. Associations between gestational diabetes and anxiety or depression: a systematic review. J Diabetes Res. 2021; 2021:9959779. PMID: 34368368.

8. ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Cusi K, et al. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2024. Diabetes Care. 2024; 47(Suppl 1):S52–S76. PMID: 38078591.

9. Graham AM, Doyle O, Tilden EL, Sullivan EL, Gustafsson HC, Marr M, et al. Effects of maternal psychological stress during pregnancy on offspring brain development: considering the role of inflammation and potential for preventive intervention. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022; 7(5):461–470. PMID: 34718150.

10. Marchetti D, Carrozzino D, Fraticelli F, Fulcheri M, Vitacolonna E. Quality of life in women with gestational diabetes mellitus: a systematic review. J Diabetes Res. 2017; 2017:7058082. PMID: 28326332.

11. Yaron M, Roitman E, Aharon-Hananel G, Landau Z, Ganz T, Yanuv I, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019; 42(7):1178–1184. PMID: 31036546.

12. Yoo JH, Kim JH. The benefits of continuous glucose monitoring in pregnancy. Endocrinol Metab (Seoul). 2023; 38(5):472–481. PMID: 37821081.

13. Bastobbe S, Heimann Y, Schleußner E, Groten T, Weschenfelder F. Using flash glucose monitoring in pregnancies in routine care of patients with gestational diabetes mellitus: a pilot study. Acta Diabetol. 2023; 60(5):697–704. PMID: 36840782.

14. Majewska A, Stanirowski PJ, Tatur J, Wojda B, Radosz I, Wielgos M, et al. Flash glucose monitoring in gestational diabetes mellitus (FLAMINGO): a randomised controlled trial. Acta Diabetol. 2023; 60(9):1171–1177. PMID: 37160787.

15. Liang X, Fu Y, Lu S, Shuai M, Miao Z, Gou W, et al. Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study. Lancet Reg Health West Pac. 2023; 39:100823. PMID: 37927990.

16. Lai M, Weng J, Yang J, Gong Y, Fang F, Li N, et al. Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial. Front Endocrinol (Lausanne). 2023; 14:1174239. PMID: 37152928.

17. Scott EM, Bilous RW, Kautzky-Willer A. Accuracy, user acceptability, and safety evaluation for the FreeStyle Libre Flash Glucose Monitoring System when used by pregnant women with diabetes. Diabetes Technol Ther. 2018; 20(3):180–188. PMID: 29470094.

18. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009; 373(9677):1773–1779. PMID: 19465232.

19. Moon JH, Kwak SH, Jang HC. Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus. Korean J Intern Med. 2017; 32(1):26–41. PMID: 28049284.

20. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999; 8(1-2):79–91. PMID: 10457741.

21. Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med. 2009; 26(4):315–327. PMID: 19388959.

22. Oluchi SE, Manaf RA, Ismail S, Kadir Shahar H, Mahmud A, Udeani TK. Health related quality of life measurements for diabetes: a systematic review. Int J Environ Res Public Health. 2021; 18(17):9245. PMID: 34501838.

23. Kim YJ, Jeong IK, Kim SG, Cho DH, Kim CH, Kim CS, et al. Changes in the quality of life in patients with type 2 diabetes mellitus according to physician and patient behaviors. Diabetes Metab J. 2020; 44(1):91–102. PMID: 31701689.

24. Bradley C, Plowright R, Stewart J, Valentine J, Witthaus E. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes. 2007; 5(1):57. PMID: 17927832.

25. Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care. 1999; 22(3):530–532. PMID: 10097946.

26. Pantzartzis KA, Manolopoulos PP, Paschou SA, Kazakos K, Kotsa K, Goulis DG. Gestational diabetes mellitus and quality of life during the third trimester of pregnancy. Qual Life Res. 2019; 28(5):1349–1354. PMID: 30600493.

27. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019; 5(1):47. PMID: 31296866.

28. Trutnovsky G, Panzitt T, Magnet E, Stern C, Lang U, Dorfer M. Gestational diabetes: women’s concerns, mood state, quality of life and treatment satisfaction. J Matern Fetal Neonatal Med. 2012; 25(11):2464–2466. PMID: 22525002.

29. Dalfrà MG, Nicolucci A, Bisson T, Bonsembiante B, Lapolla A. QLISG (Quality of Life Italian Study Group). Quality of life in pregnancy and post-partum: a study in diabetic patients. Qual Life Res. 2012; 21(2):291–298. PMID: 21633879.

30. Kopec JA, Ogonowski J, Rahman MM, Miazgowski T. Patient-reported outcomes in women with gestational diabetes: a longitudinal study. Int J Behav Med. 2015; 22(2):206–213. PMID: 25106672.

31. Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017; 390(10110):2347–2359. PMID: 28923465.

32. American Diabetes Association Professional Practice Committee. 7. Diabetes technology: standards of care in diabetes-2024. Diabetes Care. 2024; 47(Suppl 1):S126–S144. PMID: 38078575.

33. Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, et al. 2023 clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association. Diabetes Metab J. 2023; 47(5):575–594. PMID: 37793979.

34. American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy: standards of care in diabetes-2024. Diabetes Care. 2024; 47(Suppl 1):S282–S294. PMID: 38078583.

35. García-Moreno RM, Benítez-Valderrama P, Barquiel B, González Pérez-de-Villar N, Hillman N, Lora Pablos D, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022; 39(1):e14703. PMID: 34564868.

36. Lane AS, Mlynarczyk MA, de Veciana M, Green LM, Baraki DI, Abuhamad AZ. Real-time continuous glucose monitoring in gestational diabetes: a randomized controlled trial. Am J Perinatol. 2019; 36(9):891–897. PMID: 30818406.

37. Kim JH, Park EC. Impact of socioeconomic status and subjective social class on overall and health-related quality of life. BMC Public Health. 2015; 15(1):783. PMID: 26275823.